Effect of age on melanoma risk, prognosis and treatment response

Italian Melanoma Intergroup (IMI)

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

As for all types of cancer, the incidence of melanoma increases with age. However, naevus counts (the principal risk factor for melanoma) decrease with age; hence the relationship between ageing and melanoma is complex. Subjects who maintain a high naevus count after the age of 50 years are more likely to be affected by melanoma, as their lesions do not senesce. Longer telomere length, which is strongly related to age, is linked to high naevus counts/melanoma risk; thus melanoma biology is influenced by factors that slow down ageing. Age is also an important prognostic factor in melanoma. Increasing age leads to worse survival in stages I, II and III. Sentinel lymph node (SLN) status, which is a strong predictor of melanoma survival, is also affected by age, as SLN positivity decreases with age. However, the prognostic value of SLN on survival increases with age, so, again, these relationships are complex. In patients with stage IV melanoma, age impacts on survival because it affects responses to treatment. This review examines the effects of age on melanoma risk, prognostic factors and responses to treatment.

Original languageEnglish
Pages (from-to)624-629
Number of pages6
JournalActa Dermato-Venereologica
Volume98
Issue number7
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Melanoma
Therapeutics
Survival
Nevus
Nevi and Melanomas
Telomere
Incidence
Sentinel Lymph Node
Neoplasms

Keywords

  • Age
  • Ageing
  • Prognosis
  • Sentinel lymph node
  • Therapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Effect of age on melanoma risk, prognosis and treatment response. / Italian Melanoma Intergroup (IMI).

In: Acta Dermato-Venereologica, Vol. 98, No. 7, 01.01.2018, p. 624-629.

Research output: Contribution to journalReview article

Italian Melanoma Intergroup (IMI). / Effect of age on melanoma risk, prognosis and treatment response. In: Acta Dermato-Venereologica. 2018 ; Vol. 98, No. 7. pp. 624-629.
@article{fad1b00dbede4d82922ca31df167716f,
title = "Effect of age on melanoma risk, prognosis and treatment response",
abstract = "As for all types of cancer, the incidence of melanoma increases with age. However, naevus counts (the principal risk factor for melanoma) decrease with age; hence the relationship between ageing and melanoma is complex. Subjects who maintain a high naevus count after the age of 50 years are more likely to be affected by melanoma, as their lesions do not senesce. Longer telomere length, which is strongly related to age, is linked to high naevus counts/melanoma risk; thus melanoma biology is influenced by factors that slow down ageing. Age is also an important prognostic factor in melanoma. Increasing age leads to worse survival in stages I, II and III. Sentinel lymph node (SLN) status, which is a strong predictor of melanoma survival, is also affected by age, as SLN positivity decreases with age. However, the prognostic value of SLN on survival increases with age, so, again, these relationships are complex. In patients with stage IV melanoma, age impacts on survival because it affects responses to treatment. This review examines the effects of age on melanoma risk, prognostic factors and responses to treatment.",
keywords = "Age, Ageing, Prognosis, Sentinel lymph node, Therapy",
author = "{Italian Melanoma Intergroup (IMI)} and Simone Ribero and Stucci, {Luigia Stefania} and Elena Marra and Riccardo Marconcini and Francesco Spagnolo and Laura Orgiano and Virginia Picasso and Paola Queirolo and Guiseppe Palmieri and Pietro Quaglino and Veronique Bataille",
year = "2018",
month = "1",
day = "1",
doi = "10.2340/00015555-2944",
language = "English",
volume = "98",
pages = "624--629",
journal = "Acta Dermato-Venereologica",
issn = "0001-5555",
publisher = "Medical Journals/Acta D-V",
number = "7",

}

TY - JOUR

T1 - Effect of age on melanoma risk, prognosis and treatment response

AU - Italian Melanoma Intergroup (IMI)

AU - Ribero, Simone

AU - Stucci, Luigia Stefania

AU - Marra, Elena

AU - Marconcini, Riccardo

AU - Spagnolo, Francesco

AU - Orgiano, Laura

AU - Picasso, Virginia

AU - Queirolo, Paola

AU - Palmieri, Guiseppe

AU - Quaglino, Pietro

AU - Bataille, Veronique

PY - 2018/1/1

Y1 - 2018/1/1

N2 - As for all types of cancer, the incidence of melanoma increases with age. However, naevus counts (the principal risk factor for melanoma) decrease with age; hence the relationship between ageing and melanoma is complex. Subjects who maintain a high naevus count after the age of 50 years are more likely to be affected by melanoma, as their lesions do not senesce. Longer telomere length, which is strongly related to age, is linked to high naevus counts/melanoma risk; thus melanoma biology is influenced by factors that slow down ageing. Age is also an important prognostic factor in melanoma. Increasing age leads to worse survival in stages I, II and III. Sentinel lymph node (SLN) status, which is a strong predictor of melanoma survival, is also affected by age, as SLN positivity decreases with age. However, the prognostic value of SLN on survival increases with age, so, again, these relationships are complex. In patients with stage IV melanoma, age impacts on survival because it affects responses to treatment. This review examines the effects of age on melanoma risk, prognostic factors and responses to treatment.

AB - As for all types of cancer, the incidence of melanoma increases with age. However, naevus counts (the principal risk factor for melanoma) decrease with age; hence the relationship between ageing and melanoma is complex. Subjects who maintain a high naevus count after the age of 50 years are more likely to be affected by melanoma, as their lesions do not senesce. Longer telomere length, which is strongly related to age, is linked to high naevus counts/melanoma risk; thus melanoma biology is influenced by factors that slow down ageing. Age is also an important prognostic factor in melanoma. Increasing age leads to worse survival in stages I, II and III. Sentinel lymph node (SLN) status, which is a strong predictor of melanoma survival, is also affected by age, as SLN positivity decreases with age. However, the prognostic value of SLN on survival increases with age, so, again, these relationships are complex. In patients with stage IV melanoma, age impacts on survival because it affects responses to treatment. This review examines the effects of age on melanoma risk, prognostic factors and responses to treatment.

KW - Age

KW - Ageing

KW - Prognosis

KW - Sentinel lymph node

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=85050164054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050164054&partnerID=8YFLogxK

U2 - 10.2340/00015555-2944

DO - 10.2340/00015555-2944

M3 - Review article

AN - SCOPUS:85050164054

VL - 98

SP - 624

EP - 629

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

SN - 0001-5555

IS - 7

ER -